Document Detail


The effect of omeprazole on gastro-oesophageal reflux and symptoms during strenuous exercise.
MedLine Citation:
PMID:  10468675     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Strenuous exercise exacerbates gastro-oesophageal reflux and symptoms and this may be diminished by antisecretory medication with omeprazole. METHODS: Fourteen well-trained athletes (13 men, one woman), who indicated suffering from either heartburn, regurgitation or chest pain during competition running, performed two experimental trials at 2-week intervals using a randomized, double-blind, placebo-controlled crossover design. During the 6 days preceding the trial and on the trial day itself either 20 mg of omeprazole or a placebo was administered. Two hours after a low-fat breakfast and 1 h after the last study dose, the trial started with five successive 50-min periods: rest, three running periods on a treadmill, and recovery. Reflux (percentage time and number of periods oesophageal pH <4) was measured with an ambulant pH system during these periods. RESULTS: Compared to rest, reflux lasted significantly longer and occurred more frequently during the first running period, irrespective of the intervention, whereas during the second running period this effect was only observed with the placebo. Reflux occurred for longer and more frequently with the placebo than with omeprazole, but this was significant during the first two running periods only. Seven subjects reported heartburn, regurgitation and/or chest pain during exercise, irrespective of the intervention. Only a minority of the symptom periods was actually associated with acid reflux and in all cases this concerned periods with heartburn. CONCLUSIONS: Running-induced acid reflux, but not symptoms, were decreased by omeprazole, probably because most symptoms were not related to acid reflux.
Authors:
H P Peters; A F De Kort; H Van Krevelen; L M Akkermans; G P Van Berge Henegouwen; E Bol; W L Mosterd; W R De Vries
Related Documents :
10853695 - Performance level and cardiopulmonary responses during a cycle-run trial.
2396155 - Assessment of the 2.4 km run as a predictor of aerobic capacity.
3934315 - Comparison of running energetics in male and female domestic fowl.
2744675 - Marcher's digitalgia paresthetica among recruits.
19617585 - The relationship between exertional heat illness, exertional rhabdomyolysis, and malign...
9237305 - Autonomic control of the pulmonary surfactant system and lung compliance in the lizard.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Alimentary pharmacology & therapeutics     Volume:  13     ISSN:  0269-2813     ISO Abbreviation:  Aliment. Pharmacol. Ther.     Publication Date:  1999 Aug 
Date Detail:
Created Date:  1999-10-07     Completed Date:  1999-10-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8707234     Medline TA:  Aliment Pharmacol Ther     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1015-22     Citation Subset:  IM    
Affiliation:
Department of Medical Physiology and Sports Medicine, Utrecht University, Utrecht, The Netherlands. h.p.f.peters@med.uu.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anti-Ulcer Agents / therapeutic use*
Diet
Double-Blind Method
Exercise / physiology*
Female
Gastric Acidity Determination
Gastroesophageal Reflux / drug therapy*
Humans
Male
Omeprazole / therapeutic use*
Physical Fitness
Chemical
Reg. No./Substance:
0/Anti-Ulcer Agents; 73590-58-6/Omeprazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Economic analysis of step-wise treatment of gastro-oesophageal reflux disease.
Next Document:  Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflu...